Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)LeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Ocular Therapeutix (OCUL) Long-Term Debt Issuances (2017 - 2019)

Ocular Therapeutix has reported Long-Term Debt Issuances over the past 3 years, most recently at -$70000.0 for Q2 2019.

  • Quarterly results put Long-Term Debt Issuances at -$70000.0 for Q2 2019, changed N/A from a year ago — trailing twelve months through Sep 2021 was -$70000.0 (changed N/A YoY), and the annual figure for FY2023 was $82.5 million, changed.
  • Long-Term Debt Issuances for Q2 2019 was -$70000.0 at Ocular Therapeutix, down from $37.3 million in the prior quarter.
  • Over the last five years, Long-Term Debt Issuances for OCUL hit a ceiling of $37.3 million in Q1 2019 and a floor of -$13.0 million in Q4 2015.
  • Median Long-Term Debt Issuances over the past 3 years was $1.8 million (2017), compared with a mean of $7.0 million.